beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway
about
Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisAnti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipidsRole of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitroInteractions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1)Antiphospholipid antibodies: paradigm in transition.Testing for and clinical significance of anticardiolipin antibodiesSERPINE 1 Links Obesity and Diabetes: A Pilot Study.Antiphospholipid syndrome: an overview.Screening for new biomarkers for subcortical vascular dementia and Alzheimer's diseaseInhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1qInhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.Bouquet variety of antiphospholipid antibodies in recurrent pregnancy lossThe Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA.Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes.A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in miceDifferential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceInhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates.High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.Expression of anticardiolipin cofactor, human beta 2-glycoprotein I, by a recombinant baculovirus/insect cell system.Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.Circulating anti-beta2-glycoprotein I antibodies are associated with endothelial dysfunction, inflammation, and high nitrite plasma levels in patients with intermittent claudication.Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserine-exposing blood platelets.Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
P2860
Q24293734-1D1FD400-EC42-4A4D-9E1D-EBEB5C5FFA01Q24558202-08187AF0-84BE-4A30-AFD3-06F8D1E414A2Q24561680-C9C01E79-6C36-4538-BA9C-439C254962EAQ24563574-A89874E6-24D7-43E5-9EDD-E40A91B8691EQ24672569-35DBFDB0-C797-445A-BB01-5C6BE5E63314Q33382848-578806B1-9376-458A-9B5E-F114B1182270Q33766710-8E04177B-9371-40B8-AF7B-B764BD7560BCQ34340246-1835009C-6420-41F2-9E8F-B075D7BC7BC7Q35099505-44694DB6-97C7-4E2C-9B3B-8FD231A7A80CQ35428298-0F369702-69B1-4D90-A52D-9775C09A1C48Q35577462-7E60F4BB-0F15-42DB-A285-448B12731544Q35580662-D62E1524-18CD-4E7D-B006-200D49C1926CQ35631774-B17ACBB1-5C93-42F7-8151-E6B0906E9CD8Q35818105-095B6D8E-EBD6-4D75-A471-7AB02F728FB1Q35822631-1335384F-9611-4271-84AF-A6F322B7ADDAQ35822651-764C27C1-4D94-4831-81F9-5F1B2EDFBD75Q36036832-C8100DEB-DD65-4184-8562-A58FE10A20A0Q36745091-59C0E9A2-F518-49ED-9AD4-BB22ADB58C40Q36971284-B00F0D59-5A40-48CE-9D89-67C123BEDA1AQ37095385-AF438CF9-995D-426B-AF80-42647A606352Q37119024-95FAFB67-3945-4069-B638-F0F9E9425A4CQ37154155-82E37896-6183-4048-A4F3-C5CE12D030F2Q37412204-ADC93E87-D363-4B78-836E-092AADB3522BQ37471523-C9C10BEC-22AA-4450-9FE6-543DA5A84F76Q37634257-8F89DC4F-4385-4862-8C5F-225503A2A7ECQ38436472-7E6B8156-ACEA-479B-BEE9-100A939C6455Q39808627-A228EF1F-CA9C-48C4-A637-115EC3FB7CA8Q41545004-C3C396A8-BA47-46C0-953E-EDD41EF589DBQ41674799-F358C3D6-CB73-4632-BC92-4735674CC259Q41989452-F6CD6CEF-33C7-467C-A674-EF5590D6C90EQ42034633-3C800E3F-5845-4310-BE60-9701E9107E73Q42096240-CBAD24D6-3ACE-455B-8E75-E53C301F0D94Q42993559-EAB44208-DA17-48FB-A59E-198B51569574Q47901692-7A4C2078-39AB-43DC-9DDB-A9C3DCBCA168
P2860
beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway
description
1985 nî lūn-bûn
@nan
1985 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@ast
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en-gb
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@nl
type
label
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@ast
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en-gb
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@nl
prefLabel
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@ast
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en-gb
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@nl
P1433
P1476
beta 2-Glycoprotein I: a plasm ...... nsic blood coagulation pathway
@en
P2093
I Schousboe
P304
P407
P577
1985-11-01T00:00:00Z